A detailed history of Ensign Peak Advisors, Inc transactions in Pfizer Inc stock. As of the latest transaction made, Ensign Peak Advisors, Inc holds 5,061,706 shares of PFE stock, worth $126 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares
5,061,706
Previous 5,163,769 1.98%
Holding current value
$126 Million
Previous $144 Million 1.39%
% of portfolio
0.26%
Previous 0.27%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$27.7 - $31.39 $2.83 Million - $3.2 Million
-102,063 Reduced 1.98%
5,061,706 $146 Million
Q2 2024

Aug 13, 2024

SELL
$25.26 - $29.6 $6.61 Million - $7.74 Million
-261,578 Reduced 4.82%
5,163,769 $144 Million
Q1 2024

May 14, 2024

BUY
$25.89 - $29.73 $9.4 Million - $10.8 Million
363,032 Added 7.17%
5,425,347 $151 Million
Q4 2023

Feb 14, 2024

BUY
$26.13 - $33.94 $46.3 Million - $60.1 Million
1,771,860 Added 53.85%
5,062,315 $146 Million
Q3 2023

Nov 13, 2023

SELL
$32.09 - $37.51 $7.99 Million - $9.34 Million
-248,974 Reduced 7.03%
3,290,455 $109 Million
Q2 2023

Aug 14, 2023

SELL
$36.12 - $41.79 $64.9 Million - $75.1 Million
-1,797,819 Reduced 33.68%
3,539,429 $130 Million
Q1 2023

May 15, 2023

SELL
$39.39 - $51.28 $23 Million - $30 Million
-584,788 Reduced 9.87%
5,337,248 $218 Million
Q4 2022

Feb 13, 2023

SELL
$41.75 - $54.5 $21.8 Million - $28.4 Million
-521,478 Reduced 8.09%
5,922,036 $304 Million
Q3 2022

Nov 14, 2022

BUY
$43.76 - $53.42 $26.6 Million - $32.5 Million
607,762 Added 10.41%
6,443,514 $282 Million
Q2 2022

Aug 12, 2022

BUY
$46.53 - $55.17 $3.76 Million - $4.46 Million
80,888 Added 1.41%
5,835,752 $306 Million
Q1 2022

May 16, 2022

SELL
$45.75 - $56.69 $43.2 Million - $53.6 Million
-945,041 Reduced 14.11%
5,754,864 $298 Million
Q4 2021

Feb 11, 2022

BUY
$41.32 - $61.25 $73.4 Million - $109 Million
1,775,904 Added 36.07%
6,699,905 $396 Million
Q3 2021

Nov 12, 2021

BUY
$39.25 - $50.42 $29.9 Million - $38.4 Million
761,388 Added 18.29%
4,924,001 $212 Million
Q2 2021

Aug 13, 2021

SELL
$35.91 - $40.68 $1.75 Million - $1.98 Million
-48,755 Reduced 1.16%
4,162,613 $163 Million
Q1 2021

May 12, 2021

SELL
$33.49 - $37.77 $2.42 Million - $2.73 Million
-72,326 Reduced 1.69%
4,211,368 $153 Million
Q4 2020

Feb 12, 2021

BUY
$33.47 - $42.56 $55.9 Million - $71.1 Million
1,671,474 Added 63.99%
4,283,694 $158 Million
Q3 2020

Nov 12, 2020

SELL
$31.75 - $37.25 $875,887 - $1.03 Million
-27,587 Reduced 1.05%
2,612,220 $95.9 Million
Q2 2020

Aug 12, 2020

BUY
$30.12 - $36.54 $1.89 Million - $2.29 Million
62,741 Added 2.43%
2,639,807 $86.3 Million
Q1 2020

May 11, 2020

BUY
$27.03 - $38.62 $14 Million - $20 Million
517,229 Added 25.11%
2,577,066 $84.1 Million
Q4 2019

Feb 14, 2020

BUY
$32.92 - $37.36 $67.8 Million - $77 Million
2,059,837 New
2,059,837 $80.7 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $140B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Ensign Peak Advisors, Inc Portfolio

Follow Ensign Peak Advisors, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ensign Peak Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ensign Peak Advisors, Inc with notifications on news.